EA199900260A1 - Кристаллический фармацевтический продукт - Google Patents

Кристаллический фармацевтический продукт

Info

Publication number
EA199900260A1
EA199900260A1 EA199900260A EA199900260A EA199900260A1 EA 199900260 A1 EA199900260 A1 EA 199900260A1 EA 199900260 A EA199900260 A EA 199900260A EA 199900260 A EA199900260 A EA 199900260A EA 199900260 A1 EA199900260 A1 EA 199900260A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical product
crystalline pharmaceutical
methods
crystalline
bipiperidin
Prior art date
Application number
EA199900260A
Other languages
English (en)
Other versions
EA001363B1 (ru
Inventor
Стефен Торей Росс
Original Assignee
Смитклайн Бичам Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Смитклайн Бичам Корпорейшн filed Critical Смитклайн Бичам Корпорейшн
Publication of EA199900260A1 publication Critical patent/EA199900260A1/ru
Publication of EA001363B1 publication Critical patent/EA001363B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение предлагает гидрохлорид (S)-7[(4,4'-бипиперидин-1-ил) карбонил]-2,3,4,5-тетрагидро-4-метил-3-оксо-1Н-1,4-бензодиазепин-2-уксусной кислоты, способы его получения и способы его применения.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199900260A 1996-09-03 1997-08-29 Кристаллический фармацевтический продукт EA001363B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2536996P 1996-09-03 1996-09-03
PCT/US1997/015292 WO1998009629A1 (en) 1996-09-03 1997-08-29 Crystalline pharmaceutical product

Publications (2)

Publication Number Publication Date
EA199900260A1 true EA199900260A1 (ru) 1999-08-26
EA001363B1 EA001363B1 (ru) 2001-02-26

Family

ID=21825633

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199900260A EA001363B1 (ru) 1996-09-03 1997-08-29 Кристаллический фармацевтический продукт

Country Status (32)

Country Link
US (1) US6335330B1 (ru)
EP (1) EP0964684B1 (ru)
JP (1) JP2000517342A (ru)
CN (1) CN1102391C (ru)
AP (1) AP9901472A0 (ru)
AR (1) AR008154A1 (ru)
AT (1) ATE245984T1 (ru)
AU (1) AU731173B2 (ru)
BG (1) BG103196A (ru)
BR (1) BR9711981A (ru)
CA (1) CA2264607A1 (ru)
CO (1) CO4930262A1 (ru)
CZ (1) CZ71999A3 (ru)
DE (1) DE69723873T2 (ru)
DZ (1) DZ2302A1 (ru)
EA (1) EA001363B1 (ru)
ES (1) ES2205254T3 (ru)
HU (1) HUP9904077A3 (ru)
ID (1) ID18156A (ru)
IL (1) IL128782A0 (ru)
MA (1) MA24309A1 (ru)
MY (1) MY118175A (ru)
NO (1) NO991013D0 (ru)
NZ (1) NZ334438A (ru)
OA (1) OA10986A (ru)
PE (1) PE107198A1 (ru)
PL (1) PL332006A1 (ru)
SK (1) SK27699A3 (ru)
TR (1) TR199900480T2 (ru)
UY (1) UY24690A1 (ru)
WO (1) WO1998009629A1 (ru)
ZA (1) ZA977870B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19902529A1 (de) * 1999-01-22 2000-08-03 Goldwell Gmbh Haarbehandlungsmittel
FR2797400A1 (fr) * 1999-08-11 2001-02-16 Sanofi Synthelabo Associations a activite anti-thrombotique constituees de l'hydrogenosulfate de clopidogrel et d'un antagoniste des recepteurs gpiib/iiia et les compositions pharmaceutiques les contenant
WO2003059251A2 (en) 2001-10-22 2003-07-24 The Scripps Research Institute Antibody targeting compounds
US20050202151A1 (en) * 2004-03-15 2005-09-15 Land O'lakes, Inc. Method of preparing egg nuggets
KR101046977B1 (ko) * 2004-11-15 2011-07-07 삼성에스디아이 주식회사 카본나노튜브, 이를 포함한 전자 방출원 및 이를 구비한전자 방출 소자
US20070122408A1 (en) * 2005-10-20 2007-05-31 The Scripps Research Institute Fc Labeling for Immunostaining and Immunotargeting
WO2010093706A2 (en) 2009-02-10 2010-08-19 The Scripps Research Institute Chemically programmed vaccination

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD138319A1 (de) * 1978-08-08 1979-10-24 Helmut Roehnert Verfahren zur herstellung einer stabilen,kristallwasser-und kristalloesungsmittelfreien kristallform des 7-chlor-2-methylamino-5-phenyl-3h-1,4-benzodiazepin-4-oxid-hydrochlorids
ZA924760B (en) 1991-06-28 1993-03-31 Smithkline Beecham Corp Bicyclic fibrinogen antagonists
US5939412A (en) 1992-06-26 1999-08-17 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
CN1041921C (zh) 1992-12-21 1999-02-03 史密丝克莱恩比彻姆公司 双环血纤维蛋白原拮抗剂
MA23420A1 (fr) * 1994-01-07 1995-10-01 Smithkline Beecham Corp Antagonistes bicycliques de fibrinogene.

Also Published As

Publication number Publication date
HUP9904077A2 (hu) 2000-05-28
EA001363B1 (ru) 2001-02-26
ATE245984T1 (de) 2003-08-15
MA24309A1 (fr) 1998-04-01
PL332006A1 (en) 1999-08-16
PE107198A1 (es) 1999-03-21
ID18156A (id) 1998-03-05
NO991013L (no) 1999-03-02
ES2205254T3 (es) 2004-05-01
NO991013D0 (no) 1999-03-02
US6335330B1 (en) 2002-01-01
DE69723873D1 (de) 2003-09-04
AU4242597A (en) 1998-03-26
EP0964684A4 (en) 2002-05-29
IL128782A0 (en) 2000-01-31
AU731173B2 (en) 2001-03-22
EP0964684B1 (en) 2003-07-30
BG103196A (en) 1999-09-30
TR199900480T2 (xx) 1999-06-21
OA10986A (en) 2003-03-04
DZ2302A1 (fr) 2002-12-28
SK27699A3 (en) 2000-02-14
EP0964684A1 (en) 1999-12-22
NZ334438A (en) 2000-10-27
BR9711981A (pt) 1999-08-24
HUP9904077A3 (en) 2002-03-28
CN1234739A (zh) 1999-11-10
CN1102391C (zh) 2003-03-05
CA2264607A1 (en) 1998-03-12
MY118175A (en) 2004-09-30
WO1998009629A1 (en) 1998-03-12
AR008154A1 (es) 1999-12-09
JP2000517342A (ja) 2000-12-26
DE69723873T2 (de) 2004-04-22
UY24690A1 (es) 1998-02-27
ZA977870B (en) 1998-03-03
AP9901472A0 (en) 1999-03-31
CZ71999A3 (cs) 1999-08-11
CO4930262A1 (es) 2000-06-27

Similar Documents

Publication Publication Date Title
EA199800946A1 (ru) Концентрированный препарат антител
TR199600792A2 (tr) Dihaloazolopirimidinlerin hazirlanmasina yönelik proses.
HUP9902136A3 (en) Novel substituted cyclic amino acid derivatives use as pharmaceutical agents
HUP9601240A1 (en) Pyridin and pyrimidin derivatives, suitable as beta-adrenerg agonists, pharmaceutical compositions containing the same and their intermediates
MA26455A1 (fr) Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent.
ITTO930346A0 (it) Procedimento per la preparazione di derivati taurocolanici.
HUP0102400A3 (en) Substituted octalydropyrido[1,2a]pyrazin derivatives and pharmaceutical compositions containing the same
EA199900260A1 (ru) Кристаллический фармацевтический продукт
ID16192A (id) Proses pembuatan asam-asam .alpha., beta-karboksilat organik tak jenuh
MX9707974A (es) Derivados de 10, 13, 15-trioxatriciclo [9.2.1.1 9.6]-pentadecanona, procedimientos para su preparacion y medicamentos que contienen estos compuestos.
HUP9602868A3 (en) 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivative, pharmaceutical compositions containing the same and process for their preparation
FR2705671B1 (fr) Nouveaux dérivés de l'hydroxybiphényle, leur préparation et les compositions pharmaceutiques qui les contiennent.
ITTO950646A0 (it) Strumento tascabile per l'acquisizione di un segnale biologico di natura elettrica, in particolare un segnale elettrocardiografico.
MA21805A1 (fr) Derives di - substitues des n,n'-ditrimethoxybenzoyle piperazines ainsi que leur procede de preparation .
FR2691459B1 (fr) Nouveaux derives de la phenothiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
IL128500A (en) SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA[b] BENZOFURANS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EA200000112A1 (ru) Новая композиция
ITTO930661A0 (it) Derivati acidi poliamidici ad attivita' antigastrinica, procedimento per la loro preparazione e loro uso farmaceutico.
EA199800368A1 (ru) Новые промежуточные продукты и их использование для получения n,n'-мостиковых бисиндолилмалеимидов
DZ3204A1 (fr) Dérives de streptogramines, leur préparation et l es compositions qui les contiennent.
MX9200764A (es) Procedimiento para la preparacion de 3-hidroxipropanonitrilos 3-substituidos.
FR2696173B1 (fr) 1,1-dichloro-1-fluoroéthane stabilisé, prémélanges destinés à la préparation de mousses polymériques et mousses polymériques obtenues par leur mise en Óoeuvre.
NO306672B1 (no) N,N-dietyl-8,8-dipropyl-2-azaspiro[4,5]decan-2-propanamindimaleat, farmasöytisk blanding omfattende forbindelsen samt anvendelse derav
ECSP972242A (es) Producto farmaceutico cristalino
MX9200765A (es) Procedimiento para la preparacion de 3-hidroxipropanonitrilos 3-substituidos.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU